Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
If you are an investor in Applied Therapeutics and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (212) ...
Nuvation Bio: Pending Approval Shot In ROSL+ NSCLS Looks A Major Upside Catalyst
Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...
modernghana.com1d
Streamlining the Northern Development Authority: A Pathway to Sustainable Investment
The Northern Development Authority (NDA), formerly SADA, faces a critical juncture . Despite possessing significant economic ...
Grace Therapeutics, Inc.: Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update
Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug Application (NDA) Submission Anticipated First Half of ...
Genmab Publishes 2024 Annual Report
Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2024. Below is a summary of business progress in 2024, financial performance for the year and the financial outlook ...
TMCnet2d
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
As of December 31, 2024, the Company had cash and cash equivalents in the amount of $15.6 million, compared to $5.3 million on December 31, 2023. PolyPid expects that its current cash balance will be ...
Biohaven: NDA Review Of Troriluzole Isn't Only 2025 Catalyst On Deck
Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...
APLT Lawsuit Alert! Class Action Against Applied Therapeutics, Inc.
A class action lawsuit was filed against Applied Therapeutics, Inc. (APLT) by Levi & Korsinsky on December 17, 2024. The ...
APLT INVESTOR ALERT: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Stockholder Class Action Lawsuit
February 10, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both ...